Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10

被引:4
|
作者
Ohtsu, Naoko [1 ,3 ]
Ohgaki, Ryuichi [1 ,2 ]
Jin, Chunhuan [1 ]
Xu, Minhui [1 ]
Okanishi, Hiroki [1 ]
Takahashi, Ryo [3 ]
Matsui, Akiko [3 ]
Kishimoto, Wataru [3 ]
Ishiguro, Naoki [3 ]
Kanai, Yoshikatsu [1 ,2 ]
机构
[1] Osaka Univ, Dept Biosyst Pharmacol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Integrated Frontier Res Med Sci Div, Inst Open & Transdisciplinary Res Initiat OTRI, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[3] Nippon Boehringer Ingelheim Co Ltd, Pharmacokinet & Nonclin Safety Dept, Chuo Ku, 6-7-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
关键词
Organic anion; Monocarboxylate; Transporter; Functional coupling; Exogenous expression system; EXPRESSION; FAMILY; GLUTAMATE; MEMBRANE; CLONING; KIDNEY; URATE;
D O I
10.1016/j.jphs.2022.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OAT10 (SLC22A13) is a transporter highly expressed in renal tubules and transporting organic anions including nicotinate, fl-hydroxybutyrate, p-aminohippurate, and orotate. In transport assays using Xenopus oocytes and HEK293 cells, we found that apparent substrate selectivity of OAT10 was different between the expression systems, particularly less pronounced uptake of fl-hydroxybutyrate in HEK293 cells. Because functional coupling between transporters may interfere with functional properties of the transporter, we searched for endogenous transporters in HEK293 cells that could affect OAT10. By means of comprehensive approach with co-immunoprecipitation followed by LC-MS/MS analysis, we identified monocarboxylate transporter MCT1 (SLC16A1) as physically coupled with OAT10. The knockdown of MCT1 in OAT10-expressing HEK293 cells increased the uptake of fl-hydroxybutyrate and nicotinate, common substrates of OAT10 and MCT1, whereas the uptake of orotate, a substrate of only OAT10, was not affected. MCT1 is supposed to act as an escape route and mediate the efflux of nicotinate and fl-hydroxybutyrate taken up by OAT10 localized nearby MCT1, as suggested by coimmunoprecipitation. This functional coupling would explain altered apparent substrate selectivity in HEK293 cells compared with Xenopus oocytes. The findings in this study warn in transporter studies that the expression system can interfere with assessing correct transport properties due to unexpected interactions with endogenous transporters. ?? 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页码:41 / 48
页数:8
相关论文
共 41 条
  • [1] Functional characterization of human organic anion transporter 10 (OAT10/SLC22A13) as an orotate transporter
    Shinoda, Yutaro
    Yamashiro, Takahiro
    Hosooka, Akira
    Yasujima, Tomoya
    Yuasa, Hiroaki
    DRUG METABOLISM AND PHARMACOKINETICS, 2022, 43
  • [2] Identification and characterization of a novel mouse organic anion transporter (OAT10)
    Shiraya, K
    Hirata, T
    Anzai, N
    Endou, H
    Kanai, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 120P - 120P
  • [3] Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels
    Higashino, Toshihide
    Morimoto, Keito
    Nakaoka, Hirofumi
    Toyoda, Yu
    Kawamura, Yusuke
    Shimizu, Seiko
    Nakamura, Takahiro
    Hosomichi, Kazuyoshi
    Nakayama, Akiyoshi
    Ooyama, Keiko
    Ooyama, Hiroshi
    Shimizu, Toru
    Ueno, Miki
    Ito, Toshimitsu
    Tamura, Takashi
    Naito, Mariko
    Nakashima, Hiroshi
    Kawaguchi, Makoto
    Takao, Mikiya
    Kawai, Yosuke
    Osada, Naoki
    Ichida, Kimiyoshi
    Yamamoto, Ken
    Suzuki, Hiroshi
    Shinomiya, Nariyoshi
    Inoue, Ituro
    Takada, Tappei
    Matsuo, Hirotaka
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 164 - 166
  • [4] OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts
    Toyoda, Yu
    Kawamura, Yusuke
    Nakayama, Akiyoshi
    Morimoto, Keito
    Shimizu, Seiko
    Tanahashi, Yuki
    Tamura, Takashi
    Kondo, Takaaki
    Kato, Yasufumi
    Ichida, Kimiyoshi
    Suzuki, Hiroshi
    Shinomiya, Nariyoshi
    Kobayashi, Yasushi
    Takada, Tappei
    Matsuo, Hirotaka
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
    Puri, Sachin
    Stefan, Katja
    Khan, Sharuk L.
    Pahnke, Jens
    Stefan, Sven Marcel
    Juvale, Kapil
    JOURNAL OF MEDICINAL CHEMISTRY, 2022,
  • [6] Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
    Puri, Sachin
    Stefan, Katja
    Khan, Sharuk L.
    Pahnke, Jens
    Stefan, Sven Marcel
    Juvale, Kapil
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (01) : 657 - 676
  • [7] The H+-linked monocarboxylate transporter (MCT1/SLC16A1):: A potential therapeutic target for high-risk neuroblastoma
    Fang, Jun
    Quinones, Quintin J.
    Holman, Trevor L.
    Morowitz, Michael J.
    Wang, Qun
    Zhao, Huaqing
    Sivo, Frank
    Maris, John M.
    Wahl, Miriam L.
    MOLECULAR PHARMACOLOGY, 2006, 70 (06) : 2108 - 2115
  • [8] Inducible expression of Monocarboxylate Transporter 1 (Mct1/Slc16a1) in the beta cell of transgenic mice: a model of exercise induced hyperinsulinism
    Pullen, T. J.
    Rutter, G. A.
    DIABETOLOGIA, 2010, 53 : S36 - S36
  • [9] Functional Characterization of 5-Oxoproline Transport via SLC16A1/MCT1
    Sasaki, Shotaro
    Futagi, Yuya
    Kobayashi, Masaki
    Ogura, Jiro
    Iseki, Ken
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (04) : 2303 - 2311
  • [10] Beta cell specific silencing of the plasma membrane monocarboxylate transporter MCT1 (SLC16A1) is not effected through methylation of its promoter
    Pullen, T. J.
    Xavier, G. da Silva
    Kelsey, G.
    Rutter, G. A.
    DIABETOLOGIA, 2008, 51 : S195 - S195